News & Updates | Alliance Healthcare UK

Updates

SUB-TYPE: CLASS 3 RECALL

Class 3 Drug Alert (action within 5 days) Exocin 3mg/ml Eye Drops (1 X 5ml)

Allergan UK Limited is recalling 'Danish Language Packs' of the above batch which have been shipped to the UK in error along with UK packs with the same batch number.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
0861989	Exocin 3mg/ml Eye Drops	Allergan Ltd	E75048
8076556	PI Exocin 3mg/ml Eye Drops	Allergan Ltd	E75048

For stock control enquiries please contact Allergan Customer Services Team on 0800 3767975

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 Drug Alert (Caution in use only) Epilim 200 & 500mg And Sodium Valproate

Sanofi UK have been made aware of an unusual odour associated with the above batches of Epilim / Sodium Valproate Gastro-resistant tablets. The odour has variously been described as ‘fishy', ‘sweaty armpits' and ‘cannabis'. An investigation by Sanofi has identified the root cause as the aluminium foil used in the packaging of affected batches. No impact on the quality or efficacy of the tablets has been detected. Sanofi has now ceased using this foil supplier.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batches

0269803Epilim Ec Tab 200mgSanofi UKJ601
J602
J603
K1
K2
K3
K7

0173534Epilim Ec Tab 500mgSanofi UKJ602
J603
K1
K2

Alliance do not stockSodium Val Tab 200mgZentivaK1

Alliance do not stockSodium Val Tab 500mgZentivaJ601

For all enquiries about this matter, please contact Sanofi Medical Information on 0845 3727101 or email UK-medicalinformation@sanofi.com

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: COMPANY-LED RECALL

Company-Led Drug Alert Vitaros 3mg/G X 4

Takeda UK Limited is recalling the below batch of Vitaros 3mg/G X 4 because this batch was distributed to the UK market in error between 3rd March and 11th March 2015..

Please visit the: GOV.UK website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
3845286	Vitaros 3mg/G X 4	Takeda UK Limited	511742

For enquiries relating to stock return, please call your local Alliance Healthcare Limited Local Service Centre Customer Services Team.

For medical information enquiries, please contact Takeda on tel 01628 537900, email DSO-UK@takeda.com, fax 01628 526617.

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: COMPANY-LED RECALL

Company-Led Drug Alert Rienso 30mg/ml solution for infusion

Takeda UK Limited is recalling the above batches because the patient information, carton and vial label have been updated to reflect the changed mode of administration from injection to infusion.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
Alliance Do Not Stock	Rienso 30mg/ml solution for infusion	Takeda UK Ltd	240789 257893

Company contact for medical information enquiries:

Takeda UK Ltd
Tel: 01628 537900
Fax: 01628 526617
Email: DSO-UK@takeda.com

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

Class 2 Drug Alert (action within 48 hours) Mitoxantrone 2mg/ml Concentrate for Solution for Infusio

Hospira UK Limited is recalling the above batches due to a number of confirmed out of specification test results obtained during stability studies. The out of specification results relate to both adverse impurity profile and low potency..

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
Alliance Do Not Stock	Mitoxantrone 2mg/ml Concentrate for Solution for Infusion	Hospira UK Limited	Z054636AB

Alliance Healthcare do NOT stock and therefore we are not accepting stock returns.

For enquiries relating to stock return, please contact the Hospira UK Customer service team, tel: 0800 0287304; email: custserv@hospira.com

For medical information enquiries, please contact the Hospira medical information team, tel: 01926 83440; fax: 01926 834446; email: medinfouk@hospira.com

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: COMPANY-LED RECALL

Company-led drug alert Recivit Sublingual Tablets

Grunenthal Limited is recalling the affected batches below due to a manufacturing issue, there is a possibility that blisters from the above batches may contain missing and / or two tablets in a single blister cavity.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
3830791	Recivit 133mcg tabs x 30	Grunenthal Limited	14628
3830809	Recivit 267mcg tabs x 30	Grunenthal Limited	14630
3830759	Recivit 400mcg tabs x 30	Grunenthal Limited	14632
3830767	Recivit 533mcg tabs x 30	Grunenthal Limited	15025
3830775	Recivit 800mcg tabs x 30	Grunenthal Limited	14636

Please note that we have only identified 4 potential customers who have received these affected products from Alliance Healthcare and those customers will be contacted directly. The affected customers must ensure they have a AHDL "Returns Authorisation" code before attempting to hand the product(s) to the driver.

SUB-TYPE: CLASS 2 RECALL

Class 2 Drug Alert (action within 48 hours) PI Zovirax Eye Ointment 4.50g

We have received a class 2 pharmacy level recall on PI ZOVIRAX OPHTHALMIC OINTMENT 4.50G which is being carried out for the same reason as the UK Zovirax Eye Ointment recall last week.

The: MHRA website is not available as yet.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
7030877	PI Zovirax Ophthalmic Oint 4.50g	OPD/Sigma (The text on the actual box must be written in Spanish text) Doncaster (The text on the actual box must be written in Spanish text) Doncaster (The text on the actual box must be written in Italian text)	3M940 4C910 3M941

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

Class 2 Drug Alert (action within 48 hours) Zovirax Eye Ointment

GlaxoSmithKline UK is recalling the above batches of Zovirax Eye Ointment as a precaution because the batches of pharmaceutical ingredient used in their manufacture were found to contain metal particles which were outside the upper specification limit for particle size.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
0455329	Zovirax Ophthalmic Ointment 4.50g	Glaxosmithkline UK Ltd	3L942 3M941

For medical information enquiries please contact GlaxoSmithKline Medical Information, tel: 0800 221 441 email: ukmedinfo@gsk.com

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: COMPANY-LED RECALL

Company-led drug recall Phenobarbital 50mg/5ml

Nupharm Laboratories is recalling the above batches due to the reported crystallisation of the product over time..

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
Alliance do not stock	Phenobarbital 50mg/5ml, 200ml bottle	Nupharm Laboratories	DB1121A
Alliance do not stock	Phenobarbital 50mg/5ml, 200ml bottle	Nupharm Laboratories	DB1121B
Alliance do not stock	Phenobarbital 50mg/5ml, 200ml bottle	Nupharm Laboratories	DB1121C
Alliance do not stock	Phenobarbital 50mg/5ml, 200ml bottle	Nupharm Laboratories	DE2511A
Alliance do not stock	Phenobarbital 50mg/5ml, 200ml bottle	Nupharm Laboratories	DE2581A
Alliance do not stock	Phenobarbital 50mg/5ml, 200ml bottle	Nupharm Laboratories	DE2661A
Alliance do not stock	Phenobarbital 50mg/5ml, 200ml bottle	Nupharm Laboratories	DE2691A
Alliance do not stock	Phenobarbital 50mg/5ml, 200ml bottle	Nupharm Laboratories	DE2691B
Alliance do not stock	Phenobarbital 50mg/5ml, 200ml bottle	Nupharm Laboratories	DG3371A
Alliance do not stock	Phenobarbital 50mg/5ml, 100ml bottle	Nupharm Laboratories	DB1122A

Alliance Healthcare do not stock this product and are therefore not accepting stock returns.

Company contact for stock enquiries: Anne O'Grady, Head of Quality on Tel: 01244 287940 or Mobile: 07713 939118.

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.